Coronary Artery Disease clinical trials at UC Irvine

2 in progress, 1 open to eligible people

Showing trials for

  • Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

    open to eligible people ages 55 years and up

    TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.

    Orange, California and other locations

  • YN001 in Adults With Coronary Atherosclerosis

    Sorry, not currently recruiting here

    This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.

    Los Alamitos, California and other locations

Last updated: